Five things for pharma marketers to know: Monday, September 18, 2017

Five things for pharma marketers to know: Monday, September 18, 2017

Insurers rarely require prior authorization for opioids; court of appeals voids J&J win in Advil ads suit; new California law to address drug pricing

Accessible website design for users with disabilities lags far behind demand

Accessible website design for users with disabilities lags far behind demand

Too few of the billions of sites online are usable for disabled people, says AudioEye's CEO.

Is your brand's voice, male, female, human or mineral?

Is your brand's voice, male, female, human or mineral?

The rise of voice technology platforms and the connected home has turned the discussion of a brand's voice from metaphorical to physical.

Five things for pharma marketers to know: Friday, September 15, 2017

Five things for pharma marketers to know: Friday, September 15, 2017

The FDA approves first cancer biosimilar; it also approves Bayer's new lymphoma drug; clinical-trial participation for gynecological cancer drops

Sheryl Sandberg: 'Facebook must bring people together to do good'

Sheryl Sandberg: 'Facebook must bring people together to do good'

Facebook chief operating officer Sheryl Sandberg has said that in turbulent times the social network must do more than simply connect people.

Five things for pharma marketers to know: Thursday, September 14, 2017

Five things for pharma marketers to know: Thursday, September 14, 2017

One-third of clinical trials are never publicly registered; ICER revises PCSK9 cost-effectiveness analysis; flu shot linked to miscarriages

Giant brings on new brand experience lead, as Armstrong departs

Giant brings on new brand experience lead, as Armstrong departs

Aaron Sklar, formerly of Welltok, replaces Christine Armstrong, who moved on to a Silicon Valley health startup.

Q&A: On being a working mom

Q&A: On being a working mom

Guidemark Health's Tina Fascetti offers Medela's Katie Busse advice on being a working mother in healthcare marketing.

Five things for pharma marketers to know: Wednesday, September 13, 2017

Five things for pharma marketers to know: Wednesday, September 13, 2017

FDA closes pediatric study loophole; little evidence outcomes-based contracts are working; PBMs lobby against transparency efforts

Fitbit CMO Tim Rosa: 'We know consumers don't want the internet on their wrists'

Fitbit CMO Tim Rosa: 'We know consumers don't want the internet on their wrists'

Rosa talks about the wearable technology company's health and fitness plans and other areas of expansion.

Watch: Psychiatry body kicks off first recruitment campaign with emotive film

Watch: Psychiatry body kicks off first recruitment campaign with emotive film

The Royal College of Psychiatrists kicked off a six-week student recruitment campaign with a national media push and an emotive film voiced by patient testimony.

Amarin names its first chief commercial officer

Amarin names its first chief commercial officer

The drugmaker tapped Mark Salyer, who previously managed Teva's respiratory business.

Five things for pharma marketers to know: Tuesday, September 12, 2017

Five things for pharma marketers to know: Tuesday, September 12, 2017

Alexion to cut 600 jobs; Sage Therapeutics' experimental seizure drug fails to meet expectations; Apple is interested in medical and health activity

Study says drug development costs much less than previously estimated

Study says drug development costs much less than previously estimated

New research suggests that the oft-cited $2.6 billion estimate for bringing a drug to market is significantly overstated.

Allergan recruits Deion Sanders to get men to use Botox

Allergan recruits Deion Sanders to get men to use Botox

The company is looking to expand the marketing of its blockbuster cosmetic drug.

Five things for pharma marketers to know: Monday, September 11, 2017

Five things for pharma marketers to know: Monday, September 11, 2017

Teva names new CEO; Allergan transfers Restasis patent to skirt competition; Google invests in oncology

Five things for pharma marketers to know: Friday, September 8, 2017

Five things for pharma marketers to know: Friday, September 8, 2017

Pfizer receives warning letter over EpiPen manufacturing; Opdivo kidney-cancer trial shows improved survival rates; cancer patients who discuss costs with physicians pay less

Former Burson director to lead Brussels business of U.K.'s Incisive Health

Former Burson director to lead Brussels business of U.K.'s Incisive Health

Incisive Health will next month welcome Francesca Scassellati Sforzolini as head of its Brussels office.

The FDA issues its second enforcement letter of 2017

The FDA issues its second enforcement letter of 2017

The OPDP has only issued two letters in 2017, compared to 11 last year.

Five things for pharma marketers to know: Thursday, September 7, 2017

Five things for pharma marketers to know: Thursday, September 7, 2017

The FDA halts IO-combo trial for Opdivo; Lilly slashes 3,500 jobs; new asthma drug could treat wide range of patients

Five things for pharma marketers to know: Wednesday, September 6, 2017

Five things for pharma marketers to know: Wednesday, September 6, 2017

The FDA warns drugmaker over opioid promotion; Watson may not be living up to the hype; Merck acquires immuno-oncology biotech

Novo Nordisk settles allegations its sales reps obscured Victoza's risks

Novo Nordisk settles allegations its sales reps obscured Victoza's risks

The federal government alleged that the drugmaker instructed its sales reps to convey messages to doctors that downplayed the drug's safety risks.

How Lauren Schulz is shaping Dr. Reddy's OTC brands

How Lauren Schulz is shaping Dr. Reddy's OTC brands

She is director of OTC brand marketing at Dr. Reddy's Laboratories.

Five things for pharma marketers to know: Tuesday, September 5, 2017

Five things for pharma marketers to know: Tuesday, September 5, 2017

Novartis CEO Joe Jimenez to step down; Sanofi ends R&D plans for Zika vaccine; oncologists still struggle to predict metastasis

Can marketing techniques save clinical trials?

Can marketing techniques save clinical trials?

No crucial area in pharma is more desperately in need of a fix — or more stubbornly resistant to change.

Five things for pharma marketers to know: Friday, September 1, 2017

Five things for pharma marketers to know: Friday, September 1, 2017

600 patients are eligible for CAR-T therapy; the FDA halts Keytruda combo study for multiple myeloma; the regulator delays decision on Herceptin biosimilar

Omnicom continues organic growth lead over rival ad networks

Omnicom continues organic growth lead over rival ad networks

By comparison, Omnicom's client roster includes less consumer goods companies compared to rivals WPP and Publicis Groupe.

Five things for pharma marketers to know: Thursday, August 31, 2017

Five things for pharma marketers to know: Thursday, August 31, 2017

Pfizer develops Minecraft version for kids with hemophilia; Lilly to resubmit baricitinib to the FDA; pricing expert says Novartis CAR-T value contract is 'progress'

Infographic | The leaders of the global hepatitis-C market

Infographic | The leaders of the global hepatitis-C market

Despite approvals of competing products from AbbVie, Merck, and Bristol-Myers Squibb, Gilead remains the market leader.

Novartis' CAR-T therapy, now approved, faces questions about price and side effects

Novartis' CAR-T therapy, now approved, faces questions about price and side effects

The Swiss drugmaker is the first to receive FDA approval to market a CAR-T therapy.

Media is where agencies are hurting

Media is where agencies are hurting

Why is revenue growth at some of the agency groups lagging forecasts for global ad expenditure?

Five things for pharma marketers to know: Wednesday, August 30, 2017

Five things for pharma marketers to know: Wednesday, August 30, 2017

Nonprofits receive FDA approval for Chagas drug; Gilead's buyout of Kite will put it back in pricing fray; most cancer patients don't receive fertility info

Why use health plan apps? To search for specialists and understand drug coverage

Why use health plan apps? To search for specialists and understand drug coverage

Consumers younger than the age of 45 were most likely to use an app developed by their health plan.

Five things for pharma marketers to know: Tuesday, August 29, 2017

Five things for pharma marketers to know: Tuesday, August 29, 2017

Drug ads make up to 38% of prime time commercials; Merck considers whether to pursue FDA approval for anacetrapib; BMS and Daiichi partner

Havas CFO: Health agencies did not perform 'very well' in H1 2017

Havas CFO: Health agencies did not perform 'very well' in H1 2017

The Havas Health & You agencies have reported some wins, however, including new business from Sanofi and Bristol-Myers Squibb.

Experts say pharma's move to Snapchat is in the making

Experts say pharma's move to Snapchat is in the making

Alone among the best-known social platforms, Snapchat has failed to generate much enthusiasm from pharma. Here's why — and here's why that may change.

Read the complete August 2017 digital edition

Read the complete August 2017 digital edition

Read the August 2017 issue in its entirety, including our recap of the MM&M Hall of Femme event.

Five things for pharma marketers to know: Monday, August 28, 2017

Five things for pharma marketers to know: Monday, August 28, 2017

Gilead to acquire Kite; the FDA issues fewest number of warning letters since 2008; the regulator approves BI's Humira biosimilar

Why Sanofi's dengue fever vaccine fell short of expectations

Why Sanofi's dengue fever vaccine fell short of expectations

Dengvaxia's post-launch plight reflects the difficulties of launching a vaccine. Is this a harbinger for future vaccine-marketing efforts?

Top 25 vaccine products in 2016, based on U.S. sales

Top 25 vaccine products in 2016, based on U.S. sales

Pfizer's Prevnar tops the list, according to data compiled by EvaluatePharma.

Allergan and SNL's Vanessa Bayer tackle birth control questions with humor

Allergan and SNL's Vanessa Bayer tackle birth control questions with humor

The pharma company's Know Your Birth Control campaign is running for six months.

Five things for pharma marketers to know: Friday, August 25, 2017

Five things for pharma marketers to know: Friday, August 25, 2017

Google surveys for depression; patients with diabetes that adhere to their regimen had fewer ER visits; Biogen, Samsung scores Humira biosimilar approval in EU

Truth Initiative asks whether Big Tobacco is exploiting veterans and the mentally ill

Truth Initiative asks whether Big Tobacco is exploiting veterans and the mentally ill

News-style segments for MTV's Video Music Awards expose how brands have marketed cigarettes to already vulnerable groups.

Five things for pharma marketers to know: Thursday, August 24, 2017

Five things for pharma marketers to know: Thursday, August 24, 2017

Amgen publishes study assessing cost-effectiveness of Repatha; Brilinta reduces death in patients with heart-attack history; Roche drug gets priority review

GSW hires former McCann exec as president of North America

GSW hires former McCann exec as president of North America

The agency appointed Sonja Foster-Storch, previously president of McCann Echo, to fill a role that has been vacant since 2016.

Analysts on WPP: 'expected bad, got worse'

Analysts on WPP: 'expected bad, got worse'

Business analysts have generally agreed that WPP's half-year earnings fell below expectations given recent market commentary, but have offered mixed guidance going forward.

Five things for pharma marketers to know: Wednesday, August 23, 2017

Five things for pharma marketers to know: Wednesday, August 23, 2017

Doctors fret about price of Novartis' experimental CAR-T therapy; study finds digital pillboxes don't improve adherence; India awards Pfizer vaccine patent

Horizon CEO Tim Walbert knows patients because he is one

Horizon CEO Tim Walbert knows patients because he is one

He was diagnosed years ago with a handful of autoimmune conditions, treating them with drugs like Abbvie's Humira, which he helped commercialize.

Five things for pharma marketers to know: Tuesday, August 22, 2017

Five things for pharma marketers to know: Tuesday, August 22, 2017

Novartis launches MS study with Apple's ResearchKit; the FDA considering limiting risk info in drug ads; J&J loses baby powder lawsuit

Outcome Health hires former BMS exec Nancy Phelan

Outcome Health hires former BMS exec Nancy Phelan

She is working on commercial partnerships for the point-of-care company.

Investors put their money on point of care

Investors put their money on point of care

Two recent cash infusions suggest investors are bullish on point-of-care advertising. Is the channel ready for its moment in the spotlight?

Diabetes drugs must prove their value to payers, analysts say

Diabetes drugs must prove their value to payers, analysts say

CVS Health's decision to remove Lilly's Jardiance for J&J's Invokana has analysts wondering if exclusive pricing contracts could shape the future of the GLP-1 class.

Five things for pharma marketers to know: Monday, August 21, 2017

Five things for pharma marketers to know: Monday, August 21, 2017

The FDA approves Ironwood's gout drug; GSW names new president; Samsung and Takeda to partner on biologic development

Always ad '#LikeAGirl' returns to fight girls' fear of failure

Always ad '#LikeAGirl' returns to fight girls' fear of failure

Procter & Gamble has revived the campaign with a new spot tackling the lack of confidence during puberty.

Pharma's $6 billion annual ad spend targeted by media publishers

Pharma's $6 billion annual ad spend targeted by media publishers

Condé Nast, Time Inc., and Vice Media have all recently launched health content businesses.

Sanofi adds WPP to creative roster in agency review

Sanofi adds WPP to creative roster in agency review

WPP was added to Sanofi's creative agency roster and GroupM's Mindshare is the drugmaker's new global media agency of record.

Five things for pharma marketers to know: Friday, August 18, 2017

Five things for pharma marketers to know: Friday, August 18, 2017

Lawmakers to investigate pricing of MS drugs; Mylan will pay $465 million to resolve EpiPen allegations; the FDA approves Pfizer's new cancer drug

Five things for pharma marketers to know: Thursday, August 17, 2017

Five things for pharma marketers to know: Thursday, August 17, 2017

Express Scripts to limit opioid coverage; Novo's diabetes drug lowers glucose levels in trial; startup aims to give doctors access to a patient's total costs

PhRMA criticizes the FDA's research into drug advertising and promotion

PhRMA criticizes the FDA's research into drug advertising and promotion

The lobbying group said it's unclear what the agency's goal is with this research and how it promotes public health.

Study: Hiking the prices of heart drugs led to fewer sales

Study: Hiking the prices of heart drugs led to fewer sales

Prescription rates dramatically decreased following the price hikes of Valeant's Isuprel and Nitropress in 47 hospitals.

Johnson & Johnson in breach of U.K. rules over Nicorette marketing

Johnson & Johnson in breach of U.K. rules over Nicorette marketing

Johnson & Johnson has breached the U.K.'s drug regulation code in three places in promotions for smoking cessation product Nicorette.

Five things for pharma marketers to know: Wednesday, August 16, 2017

Five things for pharma marketers to know: Wednesday, August 16, 2017

Gottlieb criticizes drugmakers for 'gaming the system' on generics; investors ignore Trump's pharma criticism; docs are more supportive of single payer

W2O's Sentient adds Spitz, Viola to leadership team

W2O's Sentient adds Spitz, Viola to leadership team

Both positions were newly created as the agency has grown over the past year.

Frazier's call earns him praise, rare for a pharma CEO

Frazier's call earns him praise, rare for a pharma CEO

It's not often that pharmaceutical companies are held up as examples of morality or leadership to the general public.

Five things for pharma marketers to know: Tuesday, August 15, 2017

Five things for pharma marketers to know: Tuesday, August 15, 2017

Pfizer accuses J&J of limiting biosimilar uptake; Trump again criticizes high drug prices; WebMD to reposition site to help consumers manage their health

Biogen, Merck use predictive modeling to better negotiate value-based contracts

Biogen, Merck use predictive modeling to better negotiate value-based contracts

What's holding back value-based pricing deals from moving beyond the pilot phase?

Five things for pharma marketers to know: Monday, August 14, 2017

Five things for pharma marketers to know: Monday, August 14, 2017

Merck CEO leaves Trump's manufacturing council over Charlottesville response; researchers struggle to fill clinical trials for IO drugs; Roche shareholders sue over top-line results

Accenture wants to be world's biggest 'experience agency of record'

Accenture wants to be world's biggest 'experience agency of record'

Accenture Interactive claims it is building the first global "experience agency of record" and that it can cater for the needs of brands better than traditional agency holding companies.

Former Cleveland Clinic comms exec Angela Calman joins IBM Watson Health

Former Cleveland Clinic comms exec Angela Calman joins IBM Watson Health

Calman is joining the technology company as VP of comms for Watson Health.

Bill to allow imported drugs from Canada aims to create competition

Bill to allow imported drugs from Canada aims to create competition

The Congressional Budget Office says that Sanders' bill would save the U.S. federal government nearly $7 billion over the next decade.

Point-of-care group rolls out guidelines

Point-of-care group rolls out guidelines

The goal is to further cement point of care as a mainstream media channel.

Top 25 oncology brands in 2016, based on U.S. sales

Top 25 oncology brands in 2016, based on U.S. sales

Celgene's Revlimid tops the list, according to data compiled by EvaluatePharma.

Five things for pharma marketers to know: Friday, August 11, 2017

Five things for pharma marketers to know: Friday, August 11, 2017

Egalet slashes workforce in favor of opioid education; Novo's experimental obesity drug reports positive results; Trump declares opioid crisis a national emergency

Five things for pharma marketers to know: Thursday, August 10, 2017

Five things for pharma marketers to know: Thursday, August 10, 2017

One in 12 docs took payments from opioid makers; hospitals cut use of Isuprel and Nitropress after price hikes; AI helping develop ALS drugs

Infographic | What patients want: a better healthcare experience

Infographic | What patients want: a better healthcare experience

Patients are demanding more of their healthcare experience — and that includes from their healthcare providers, according to two new surveys.

A day at work with Makovsky's Rob Schachter

A day at work with Makovsky's Rob Schachter

A mentor once told him to keep learning and stay out of his comfort zone.

Five things for pharma marketers to know: Wednesday, August 9, 2017

Five things for pharma marketers to know: Wednesday, August 9, 2017

The FDA on pace for record generic drug approvals; CVS Health CEO doubts Amazon's entrance to pharmacy market; Sanofi to develop cancer immunotherapy

New ANA report finds 'transparency concerns' in production process

New ANA report finds 'transparency concerns' in production process

In a follow-up to last year's media report, the Association of National Advertisers details "dysfunction" and rigged bids.

Drugmakers test out Tumblr, to tap specific audiences

Drugmakers test out Tumblr, to tap specific audiences

Pharma has more or less ignored the social-blog hybrid Tumblr, with the number of programs using it countable on a single hand. That's about to change.

Healthcare agencies intensify college recruiting tactics

Healthcare agencies intensify college recruiting tactics

They are using social media campaigns, apprentice programs, and hands-on internships to recruit young, innovative talent right out of school.

Five things for pharma marketers to know: Tuesday, August 8, 2017

Five things for pharma marketers to know: Tuesday, August 8, 2017

A shorter list of risks in TV ads helps consumer comprehension; medical-school choice affects prescribing patterns; reps often show docs the same info

Pharma companies, now marketing high-science drugs, rely more on medical affairs

Pharma companies, now marketing high-science drugs, rely more on medical affairs

Five years ago, the notion of medical science liaisons as a guiding voice in the marketing mix was borderline preposterous. Now they're called upon early and often.

Lynn O'Connor Vos to leave ghg; Erin Byrne named CEO

Lynn O'Connor Vos to leave ghg; Erin Byrne named CEO

O'Connor Vos has served as CEO of the WPP Health & Wellness agency since 1994.

Allergan ramps up promotion for new rosacea drug

Allergan ramps up promotion for new rosacea drug

The drugmaker began advertising for Rhofade on Facebook in early August.

Five things for pharma marketers to know: Monday, August 7, 2017

Five things for pharma marketers to know: Monday, August 7, 2017

Insurers deny coverage of generic drugs; Teva to lay off 7,000 employees; Shkreli convicted of securities fraud

Roundtable: Market access takes center stage

Roundtable: Market access takes center stage

Participants in this roundtable explore how digital forms of data are poised to illuminate the reimbursement pathway, as market access gets its closeup.

Five things for pharma marketers to know: Friday, August 4, 2017

Five things for pharma marketers to know: Friday, August 4, 2017

AbbVie's new HCV drug is cheaper than Gilead's Harvoni; Lilly's experimental migraine drugs beats placebo; Fitbit to launch smartwatch

Astellas promotes Moyra Knight to comms, corporate citizenship role

Astellas promotes Moyra Knight to comms, corporate citizenship role

She will also continue to serve as president of the Astellas U.S.A. Foundation.

Five things for pharma marketers to know: Thursday, August 3, 2017

Five things for pharma marketers to know: Thursday, August 3, 2017

FDA committee votes against J&J arthritis drug; scientists successfully edit genes; Shire mulls ADHD spin off

W2O's Twist hires new president

W2O's Twist hires new president

Former Edelman executive Mary Corcoran replaces Annalise Coady, who becomes president of W2O EMEA.

Johnson & Johnson is big winner in CVS diabetes formulary changes

Johnson & Johnson is big winner in CVS diabetes formulary changes

CVS Health will remove Lilly's Jardiance in favor of J&J's Invokana.

Five things for pharma marketers to know: Wednesday, August 2, 2017

Five things for pharma marketers to know: Wednesday, August 2, 2017

Celgene and Agios secure FDA approval for AML drug Idhifa; GSK hires chief digital and technology officer; Pfizer wants tax reform before M&A engagement

From diversity to pricing issues, BMS marketing chief strikes a balance

From diversity to pricing issues, BMS marketing chief strikes a balance

Susan Sweeney has earned a reputation for such pragmatism and attentiveness to the things that really matter.

Read the complete July 2017 digital edition

Read the complete July 2017 digital edition

Read the 2017 Agency Issue in its entirety.

Five things for pharma marketers to know: Tuesday, August 1, 2017

Five things for pharma marketers to know: Tuesday, August 1, 2017

Express Scripts removes 64 branded drugs from 2018 formulary; wearable market can regain momentum, analysts say; FDA accepts Herceptin biosimilars for review

Photo | The 2017 Hall of Femme

Photo | The 2017 Hall of Femme

Meet 13 of our 16 Hall of Femme honorees.

Five things for pharma marketers to know: Monday, July 31, 2017

Five things for pharma marketers to know: Monday, July 31, 2017

FDA launches digital health pre-certification pilot; J&J's experimental RA drug raises safety concerns; AstraZeneca gets breakthrough status for Imfinzi

Drugmakers turn to tech to better demonstrate empathy

Drugmakers turn to tech to better demonstrate empathy

Frustrated by its inability to empathize with patients, pharma has turned to tech to teach providers and caregivers what illness really feels like.

Cannabis nutrition company focuses on education

Cannabis nutrition company focuses on education

A particular focus is put on the emerging research about cannabis and its benefits for the human body.

Five things for pharma marketers to know: Friday, July 28, 2017

Five things for pharma marketers to know: Friday, July 28, 2017

Drugmakers inconsistently share clinical trial data; AstraZeneca's share price falls after Mystic results; some pregnancy apps share info with marketers